awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q44115102-436D361B-EB0F-42C9-83E3-E6FEA314137B
Q44115102-436D361B-EB0F-42C9-83E3-E6FEA314137B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q44115102-436D361B-EB0F-42C9-83E3-E6FEA314137B
Sustained cholinesterase inhibition in AD patients receiving rivastigmine for 12 months.
P1476
Q44115102-436D361B-EB0F-42C9-83E3-E6FEA314137B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q44115102-436D361B-EB0F-42C9-83E3-E6FEA314137B
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
c7d56d8bfe747f676737349f95a577b4a4799c2b
P1476
Sustained cholinesterase inhibition in AD patients receiving rivastigmine for 12 months.
@en